# US 2002/0120305 A1 · Method and apparatus for assessing cardiac funtional status

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2002/0120305 A1
- Document ID: US20020120305A1
- Status: Published application
- Kind: A1
- Application number: 09/551,310
- Filed: 2000-04-18
- Published: 2002-08-29
- Earliest claimed: 2000-04-18
- Assignees: Cardiac Pacemakers, Inc.
- Inventors: Weimin Sun; Veerichetty Kadhiresan; Bruce H. KenKnight; Richard S. Sanders
- Web page: https://patentgrep.com/patent/US20020120305A1

## CPC

- A61N 1/36542: {controlled by body motion, e.g. acceleration}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

A method for assessing cardiac function suitable for incorporation into an implantable cardiac rhythm management device. By measuring daily exertion levels in accordance with the invention, an assessment of cardiac function can be made that has been found to correlate well with conventional clinical classifications. The invention also provides for assessing cardiac function in conjunction with different pacing schemes designed to treat heart failure and using the assessment to select the best such scheme for the patient.

## Claims

### Claim 1

A method for assessing a patient's cardiac functional status, comprising:
measuring a moving average over a specified averaging period of exertion levels attained by the patient during daily activities;
extracting daily maximal exertion levels from the measured moving average exertion levels for a specified number of days; and,
classifying the patient's cardiac functional status based upon the daily maximum daily exertion levels.

### Claim 2 (depends on 1)

The method of claim 1 wherein the exertion levels are moving averaged over a time period of between approximately 30 seconds and 10 minutes.

### Claim 3 (depends on 1)

The method of claim 1 wherein the exertion levels are measured by an implantable accelerometer.

### Claim 4 (depends on 1)

The method of claim 1 wherein the exertion levels are measured by an implantable minute ventilation sensor.

### Claim 5 (depends on 1)

The method of claim 1 wherein the steps are performed automatically at periodic times by an implantable device.

### Claim 6 (depends on 5)

The method of claim 5 wherein the daily maximal exertion levels are registered and stored by the device.

### Claim 7 (depends on 6)

The method of claim 6 further comprising transmitting the registered and stored daily maximal exertion levels to an external programmer for the device.

### Claim 8 (depends on 1)

The method of claim 1 further comprising computing and storing averages of daily maximal exertion levels over a specified period of time.

### Claim 9 (depends on 1)

The method of claim 1 further comprising automatically adjusting a pacing scheme of the device based upon the extracted maximal exertion levels.

### Claim 10 (depends on 5)

The method of claim 5 further comprising automatically selecting a drug therapy capable of being delivered by the device.

### Claim 11 (depends on 5)

The method of claim 5 further comprising activating a selected diagnostic monitoring feature performed by the device when measured maximal exertion levels reach a selected threshold.

### Claim 12 (depends on 5)

The method of claim 5 further comprising turning off or turning on device therapeutic features in accordance with measured maximal exertion levels.

### Claim 13 (depends on 5)

The method of claim 5 further comprising:
performing a test sequence in which different therapies capable of being delivered by the device are tried while maximal exertion levels associated with the therapy are measured; and,
automatically reconfiguring device parameter settings to select the optimum therapy for delivery by the device in accordance with the measured exertion levels.

### Claim 14 (depends on 13)

The method of claim 13 wherein the device is a cardiac pacemaker and the different therapies are pacing schemes.

### Claim 15 (depends on 1)

A cardiac rhythm management device, comprising:
sensing channels for sensing atrial and ventricular depolarization signals, each channel including an electrode and a sense amplifier;
a pulse generator for delivering pacing pulses to the atrium and/or ventricle;
an exertion level sensor; and,
a processor for controlling the delivery of pacing pulses in response to elapsed time intervals and detected depolarization signals in accordance with a programmed mode, wherein the processor is programmed to perform the method set forth in claim 1.

### Claim 16 (depends on 15)

The device of claim 15 wherein the processor is programmed to automatically adjust a pacing scheme of the device based upon the extracted maximal exertion levels.

### Claim 17 (depends on 16)

The device of claim 16 wherein the processor is programmed to perform a testing sequence in which different pacing schemes are tried for predetermined periods and a patient's functional status is assessed while each scheme is tried.

### Claim 18 (depends on 17)

The device of claim 17 wherein the processor is programmed to insert a wash out period between trials of different pacing schemes.

### Claim 19 (depends on 17)

The device of claim 17 wherein the processor is programmed to automatically select for use the pacing scheme resulting in the most improved functional status of a patient as determined by the testing sequence.

### Claim 20 (depends on 15)

The device of claim 15 wherein the processor is programmed to activate a diagnostic monitoring operation when there is a change in the patient's status as reflected by measured exertion levels.
